05.07.2013 Views

BD Biopharmaceutical Production

BD Biopharmaceutical Production

BD Biopharmaceutical Production

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

• Custom Media Program—<strong>BD</strong> has available a custom media program to meet<br />

individual customer requirements. The program offers three levels of customization,<br />

from special packaging and QC testing requirements to full formula optimization<br />

services. It is our goal to service our customers with the highest level of technical<br />

support and manufacturing flexibility.<br />

• Media Optimization Program—At the highest level of technical interaction, the<br />

Custom Media Program allows customers to outsource media optimization to <strong>BD</strong>,<br />

thus allowing them to focus resources in other critical areas. By accessing <strong>BD</strong> expertise<br />

in media development, customers can take advantage of our experience in yield<br />

enhancement and media formulation scale-up.<br />

• Dedicated animal-free equipment and environment—With the rising concerns<br />

over bovine spongiform encephalopathies and transmissible spongiform encephalopathies<br />

(BSE/TSE), <strong>BD</strong> has met the challenge by dedicating process equipment to the<br />

production of animal-free products. Specific orders can be produced in this animalfree<br />

environment.<br />

• Heightened Regulatory Compliance—<strong>BD</strong> plants are ISO 9001 and 13485<br />

Certified, and regularly inspected by the FDA to conform with our cGMP manufacturing<br />

practices. We also offer the biotherapeutic industry comprehensive programs in<br />

documenting raw material origin, manufacturing change control and Drug Master<br />

Files (DMF) for key products.<br />

History<br />

How did <strong>BD</strong> build this unmatched foundation to support the <strong>Biopharmaceutical</strong> industry?<br />

In 1955, <strong>BD</strong> acquired the Baltimore Biological Laboratory (BBL) of Baltimore, Maryland,<br />

and used its expertise to continually advance the clinical market with prepared media and<br />

diagnostic tools. In 1997, <strong>BD</strong> acquired Difco Laboratories of Detroit, Michigan. Since that<br />

acquisition, <strong>BD</strong> has merged Difco Laboratories and BBL Microbiology Systems into one<br />

division that provides customers with media, peptones, hydrolysates and extracts. Today,<br />

<strong>BD</strong> is one of the largest microbiology companies in the world, offering a broad range of<br />

microbiology and cell culture products worldwide.<br />

Difco Contributions to the <strong>BD</strong> Product Line<br />

Beginning in 1895, Difco Laboratories produced high quality enzymes, dehydrated tissues<br />

and glandular products to aid in the digestion process. The knowledge gained from<br />

processing animal tissues, purifying enzymes and performing dehydration<br />

procedures allowed a smooth transition to the preparation of dehydrated culture<br />

media, in addition to its peptones.<br />

Meat tissue and other protein digests were developed to stimulate growth of<br />

bacteria and fungi. Extensive research led to the development of Difco Bacto<br />

Peptone, which was introduced in 1914. Since then, Bacto Peptone continues<br />

to be recognized as the ‘premium quality’ standard for all other peptones.<br />

2 <strong>BD</strong> BIOPHARMACEUTICAL PRODUCTION

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!